Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ibex Ltd (IBEX)

Ibex Ltd (IBEX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 290,572
  • Shares Outstanding, K 17,214
  • Annual Sales, $ 523,120 K
  • Annual Income, $ 31,580 K
  • 60-Month Beta 0.74
  • Price/Sales 0.61
  • Price/Cash Flow 5.94
  • Price/Book 1.88
Trade IBEX with:

Options Overview Details

View History
  • Implied Volatility 26.03% ( +6.47%)
  • Historical Volatility 24.15%
  • IV Percentile 48%
  • IV Rank 24.54%
  • IV High 105.17% on 02/09/24
  • IV Low 0.30% on 07/20/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 12
  • Open Int (30-Day) 9

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.30
  • Growth Rate Est. (year over year) +332,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.36 +8.07%
on 07/05/24
17.38 -4.49%
on 07/16/24
+0.81 (+5.13%)
since 06/18/24
3-Month
13.00 +27.69%
on 04/25/24
17.38 -4.49%
on 07/16/24
+3.24 (+24.25%)
since 04/19/24
52-Week
11.45 +45.01%
on 09/14/23
21.10 -21.33%
on 08/07/23
-3.45 (-17.21%)
since 07/19/23

Most Recent Stories

More News
Why IBEX Limited Stock Fell Today

The outsourcing company saw solid client growth but is struggling with soft volumes from existing customers.

IBEX : 16.60 (-1.66%)
Why Ibex Stock Is Plummeting Today

Ibex stock has now fallen 45% across 2023's trading.

RY : 111.13 (-0.85%)
RY.TO : 152.64 (-0.72%)
IBEX : 16.60 (-1.66%)
U.S. Inflation News Due out Next Week

Monday U.S. Featured Earnings Oracle Corporation (NYSE:ORCL) (Q1) Reported EPS of 90 cents ...

FLOW.TO : 0.1750 (+2.94%)
GRA.TO : 2.46 (+1.23%)
CXI.TO : 25.80 (-0.50%)
ORCL : 138.56 (+0.38%)
CASY : 376.65 (+0.06%)
INNV : 6.07 (+1.85%)
EPM : 5.62 (-0.88%)
TSP : 0.2500 (-5.66%)
CBRL : 43.72 (-0.77%)
REVG : 24.58 (+2.85%)
IBEX : 16.60 (-1.66%)
ADBE : 551.00 (-1.05%)
NEJM Evidence Publishes Results for ImmunityBio’s QUILT 3.032 Registrational Trial of IL-15 Superagonist N-803 Plus BCG in Patients with Bladder Cancer

NEJM Evidence has published results from the QUILT 3.032 trial studying N-803 plus BCG in adults with NMIBC CIS with or without Ta/T1 papillary disease. These positive data form the basis of ImmunityBio’s...

IBEX : 16.60 (-1.66%)
IBEX Limited (IBEX) Q4 2022 Earnings Call Transcript

IBEX earnings call for the period ending June 30, 2022.

IBEX : 16.60 (-1.66%)
ibex Selected “Best Digital Customer Experience” Finalist for ICMI’s 2022 Global Contact Center Awards

WASHINGTON, July 21, 2022 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer...

IBEX : 16.60 (-1.66%)
ibex to Sponsor CCW Customer Contact Week 2022

Award-Winning BPO Innovator to Host an Exclusive Luncheon for CX Leaders...

IBEX : 16.60 (-1.66%)
ibex Welcomes Dan Hess as Senior Vice President of Business Development for Healthcare Vertical

Continues to Expand Healthcare Market Presence with Innovative CX Solutions...

IBEX : 16.60 (-1.66%)
ibex to Participate in 2022 Baird Global Consumer, Technology & Services Conference

WASHINGTON, May 19, 2022 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement...

IBEX : 16.60 (-1.66%)
IBEX Limited (IBEX) Q3 2022 Earnings Call Transcript

IBEX earnings call for the period ending March 31, 2022.

IBEX : 16.60 (-1.66%)

Business Summary

IBEX Limited is a provider of outsourced CX solutions. It offers customer support, technical support, inbound/outbound sales, business intelligence and analytics, digital demand generation and CX surveys and feedback analytics service. IBEX Limited is based in Washington, United States.

See More

Key Turning Points

3rd Resistance Point 17.29
2nd Resistance Point 17.09
1st Resistance Point 16.85
Last Price 16.60
1st Support Level 16.41
2nd Support Level 16.21
3rd Support Level 15.97

See More

52-Week High 21.10
Fibonacci 61.8% 17.41
Last Price 16.60
Fibonacci 50% 16.27
Fibonacci 38.2% 15.13
52-Week Low 11.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar